







Oxytocin Acetate
Oxytocin Acetate from Super Human Peptides UK is a synthetic version of the naturally occurring mammalian nonapeptide. Endogenously produced in the hypothalamus and released by the posterior pituitary gland, it acts as both a systemic hormone and a powerful central neuropeptide. In laboratory research, Oxytocin is the primary model for investigating the neuroendocrinology of social bonding, maternal behavior, and trust.
Researchers utilize this peptide to study its modulatory effects on the amygdala—specifically its ability to reduce fear conditioning and stress responses. Beyond behavioral science, it is also studied for its physiological roles in uterine contraction and lactation. Produced under GMP-compliant conditions and verified for 99% purity or higher, Oxytocin Acetate is an essential tool for advanced neurological and psychiatric research.
- —Central Neuropeptide: Master regulator of mammalian social behavior and bonding pathways.
- —High Purity: 99% purity or higher (verified by HPLC and MS analysis).
- —Neuroendocrine Modulator: Studied for its effects on both the central nervous system and peripheral tissues.
- —Quality Standard: GMP / ISO certified manufacturing.
- —Social Cognition and Bonding: Studying the neurochemical basis of trust, pair bonding, and maternal attachment.
- —Fear Extinction: Researching the peptide's inhibitory effect on amygdala hyperactivation during stress and anxiety models.
- —Neuropsychiatric Models: Preclinical investigations into therapeutic pathways for autism spectrum disorders (ASD) and schizophrenia.
- —Pain Modulation: Investigating the central analgesic properties of oxytocin in nociceptive networks.
- —Autonomic Nervous System: Studies on heart rate variability and the buffering of the hypothalamic-pituitary-adrenal (HPA) axis under stress.
Oxytocin was the first polypeptide hormone to be sequenced and synthesized, an achievement that earned Vincent du Vigneaud the Nobel Prize in 1955. In modern neurobiology, laboratory studies have shifted heavily toward its behavioral impacts. Research by Kosfeld et al.
(2005) famously demonstrated that oxytocin administration significantly increases trust and pro-social behaviors in behavioral models. Subsequent animal and functional imaging studies have shown that Oxytocin acts directly on the amygdala to dampen fear and anxiety responses. Because it effectively buffers the body's stress response (lowering cortisol and reducing blood pressure), it remains one of the most heavily researched neuropeptides for models simulating social deficit disorders, severe anxiety, and post-traumatic stress.
- 1.Kosfeld, M. et al., "Oxytocin increases trust in humans," Nature, 2005.
- 2.Meyer-Lindenberg, A. et al., "Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine," Nature Reviews Neuroscience, 2011.
- 3.Insel, T.R., "The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior," Neuron, 2010.
- 4.Kirsch, P. et al., "Oxytocin modulates neural circuitry for social cognition and fear in humans," The Journal of Neuroscience, 2005.


